Navigation Links
Grant to fund research into eradicating the leukemia stem cell

The leukemia stem cellthe root cause of all acute leukemias represents a small population of cells in patients that are difficult to eliminate with standard treatments available today. Though current chemotherapy can produce temporary remission in leukemia survivors, they remain at risk of experiencing a recurrence and dying from the disease. The one exception is the remarkable cure of a rare form of leukemia called acute promyelocytic leukemia (APL), which came about from combining differentiation therapy with chemotherapy, and was pioneered by the collaboration between scientists at the Samuel Waxman Cancer Research Foundation (SWCRF) and the Shanghai Institute of Hematology (SIH) in China in 1982.

Now, a three-year grant of $375,000 from the Emerald Foundation, Inc. will further expand the collaboration between researchers from the SWCRF and researchers at the SIH. The SWCRF/Emerald Foundation, Inc. Global Collaborative Grant will fund critical research to identify new and more powerful drugs that can restore normal differentiation and cell growth to leukemia stem cells.

"The Emerald Foundation, Inc. seized the opportunity to partner with the Samuel Waxman Cancer Research Foundation in order to develop a cure for cancer. We truly believe in SWCRF's collaborative Institute Without Walls, which is made up of internationally-recognized scientists," said Gloria Thakuria, the scientific program officer at the Emerald Foundation, Inc. "It is through the collaboration between foundations, as well as the collaborations between scientists around the world that we will discover a cure for this deadly disease."

Gwen Darien, the executive director of the Foundation, agreed. "Collaboration is a hallmark of the Waxman Foundation's 35-year history, and has helped lead the SWCRF to make significant breakthroughs in cancer research," said Darien. "We are truly excited about partnering with the Emerald Foundation, Inc. in this collaborative grant to improve the lives of patients and families worldwide."

The grant will fund the following research projects:

  • The development and testing of a compound extracted from medicinal herbs known as Oridonin and its derivatives to attack the leukemia stem cell in clinical trials.

  • The utilization of mass sequencing analyses to better understand the leukemia stem cell.

  • Identification of leukemia stem cells in acute myeloid leukemia for further research in disease progression and treatment response.

The Foundation's mission has long focused on supporting cancer research that offers patients minimally toxic treatments, said Samuel Waxman, M.D., the scientific director of the SWCRF. "Eradicating the leukemia stem cell is the next logical step to fulfilling the Foundation's mission and goal of improving the quality of life and care for cancer patients," he said.


Contact: Jenny Song
Samuel Waxman Cancer Research Foundation

Related biology news :

1. LSUHSC awarded $2 million dollar grant to prevent pneumonia linked to immune deficiency
2. The Samuel Waxman Cancer Research Foundation awards $1.54 million in research grants for 2010-2011
3. MSU researchers awarded $9.1 million grant to battle malaria in Malawi
4. Dr. Jayne Fulkerson receives $3.2 million NIH grant
5. NSF grant will develop new online hub for biochemistry, molecular biology educators
6. CIMIT announces $3 million in medical research grants
7. NHLBI grants $1.47 million to study red blood cell transfusion storage times and bioactivity
8. University of Chicago Press book wins Grantham Prize
9. NYU Langone Medical Center receives $5.4 million NYSTEM grant for stem cell research
10. Team of UC scientists awarded $2 million NIH grant for better flu diagnoses
11. Major magnet grant to advance state-of-the-art in chemical analysis
Post Your Comments:
(Date:11/26/2015)... Research and Markets ( ) has ... - Technology and Patent Infringement Risk Analysis" report ... --> Fingerprint sensors using capacitive technology represent ... sensor vendor Idex forecasts an increase of 360% of ... and of the fingerprint sensor market between 2014 and ...
(Date:11/20/2015)... 2015 NXTD ) ("NXT-ID" or ... growing mobile commerce market and creator of the Wocket® ... was recently interviewed on The RedChip Money Report ... weekend on Bloomberg Europe , Bloomberg Asia, Bloomberg ... NXTD ) ("NXT-ID" or the "Company"), a biometric ...
(Date:11/19/2015)... Calif. , Nov. 19, 2015  Based on ... Frost & Sullivan recognizes BIO-key with the 2015 Global ... Each year, Frost & Sullivan presents this award to ... line catering to the needs of the market it ... product line meets and expands on customer base demands, ...
Breaking Biology News(10 mins):
(Date:11/27/2015)... ... November 27, 2015 , ... Pittcon is pleased to announce ... offered in symposia, oral sessions, workshops, awards, and posters. The core of ... applications such as, but not limited to, biotechnology, biomedical, drug discovery, environmental, food ...
(Date:11/27/2015)... India , November 27, 2015 /PRNewswire/ ... --> Growing popularity of companion diagnostics ... in cancer biomarkers market with pharmaceutical companies ... in-demand companion diagnostic tests. ... --> Complete report on global cancer ...
(Date:11/26/2015)... , November 26, 2015 ... --> Accutest Research Laboratories, a ... Research Organization (CRO), has formed a ... Center - Temple Health for joint ... ,     (Photo: ) , ...
(Date:11/26/2015)... , England , November 26, 2015 ... Lightpoint Medical, an innovative medical device company specializing in imaging ... grant from the European Commission as part of the Horizon ... the company to carry out a large-scale clinical trial in ... -->      (Logo: , --> ...
Breaking Biology Technology: